Commercial strategy and funding

Know whether your product can win in the US market, what it will take to get there, and how you’ll fund it, before you commit to development or launch. Shorelight Medical gives inventors, startups and established life science companies the research, strategy and funding plan that investors, partners and regulators expect to see.

Who It's For

- Established and international companies evaluating a new product or US market entry

- Startups preparing for investors, grants or a funding round

- Inventors and clinicians testing whether an idea is worth developing

What's included

Market research and intelligence

- Market analysis and validation: market size, target customers, pricing, and whether US buyers will adopt your product

- Customer insights: research with the clinicians, buyers and patients who will use or pay for it

- Competitive intelligence: who you're up against and how to position against them

- Healthcare market analytics: the data behind your market size, pricing and growth assumptions

Commercial strategy

- Commercial readiness assessment: where you stand today and what's needed before launch

- Business and strategic plans: investor-ready, with milestones, budget and decision points from concept to launch

- Customer and channel segmentation: which customers and channels to prioritize first

- Risk evaluation: regulatory, reimbursement, manufacturing and commercial risks, and how to reduce them

- Product valuation: an estimate of your product's market value for investors, licensing or acquisition talks

Funding

- Non-dilutive funding strategy: identifying and pursuing SBIR/STTR, NIH and ARPA-H grant opportunities, aligned with your commercialization plan

- Investor presentations and outreach: an investor-ready pitch deck, plus outreach and introductions to investors

Strategic partnerships

- Partnership strategy: identifying the partnerships your plan depends on, such as co-development, licensing, distribution and health-system pilots, and when to pursue each

- Access to our partner network: vetted partners for every stage of commercialization, from regulatory, reimbursement and patent counsel to manufacturing, logistics, distribution and marketing

- Partner selection and introductions: shortlisting and introducing the right partners for your product, then coordinating them as one team

How it works

Free 1-hour discovery call

We learn about your product, goals and timeline, and tell you plainly whether and how we can help. No cost and no obligation.

Proposal

If there’s a fit, we send a written proposal with scope, timeline and fees. Paid work, including any further discovery sessions, begins only after you approve it.

Research and Analysis

We study the market, customers, competitors and funding options.

Plan Delivery

You receive a written plan and a working session to walk through it.

Next Steps

Use the plan on your own, or have Shorelight carry it out with you.

Business consultant reviewing a market plan with a client

Why Shorelight

Our plans are built by people who have sold to US hospitals, clinics and physicians and launched new medical products, so they reflect how US buyers actually decide.

  • More than 30 years of combined experience in medtech and life science commercialization, spanning sales, product development, marketing strategy and market launch.
  • Founder-led. Founder and CEO Stephen Brown brings 17 years of sales experience, 13 of them in medical device sales, along with experience in product development and new product launches.
  • Marketing and commercialization expertise. Our team brings marketing strategy and execution plus hands-on commercialization experience, so your product launches with a clear message and a plan to reach buyers.
  • One team, trusted partners. A vetted network of partners across every service (product development, regulatory and quality, reimbursement and market access, sales and marketing, and manufacturing and supply chain), all coordinated by Shorelight.

FAQ

Can you help us raise money?

We prepare the business plan, market data and valuation investors ask for, build your investor presentation, and handle investor outreach and introductions. When it’s time to structure a deal, we introduce you to licensed brokers and merger and acquisition (M&A) attorneys from our partner network.

We help you identify the right SBIR/STTR, NIH and ARPA-H grant opportunities and shape your approach so it supports your commercialization plan.

Most take 3–6 weeks, depending on the product and how much data already exists.

For international companies, the plan covers US regulatory requirements, reimbursement, distribution options and the cost of entering the market.

Not sure if your product is ready for the US market?

Let’s talk.

Schedule a discovery call: a one-hour conversation where we get to know your product, your company and your goals, so we can see if and how we can help.